Literature DB >> 21308173

Treatment of type 2 diabetes in Latin America: a consensus statement by the medical associations of 17 Latin American countries. Latin American Diabetes Association.

Juan Rosas Guzmán1, Ruy Lyra, Carlos A Aguilar-Salinas, Saulo Cavalcanti, Felix Escaño, Marcos Tambasia, Elizabeth Duarte.   

Abstract

Latin America faces unique challenges in the treatment of type 2 diabetes mellitus. The Asociación Latinoamericana de Diabetes (Latin American Diabetes Association, ALAD) brought together medical associations in 17 countries in Latin America to produce a consensus statement regarding the treatment of type 2 diabetes. The goal of the document is to provide practical recommendations that will guide clinicians through a simple decision-making process for managing patients. The cornerstone elements for therapeutic decision making are: severity of hyperglycemia, clinical condition of the patient (stable or with metabolic decompensation), and body mass index. The consensus includes a section devoted specifically to patients with obesity. Information is presented as highly-relevant clinical questions. The algorithm is based on the scientific recommendations of the 2006 ALAD guidelines (a document prepared using an evidence-based approach) and data from recent randomized controlled studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21308173     DOI: 10.1590/s1020-49892010001200008

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  15 in total

Review 1.  Public Policies and Interventions for Diabetes in Latin America: a Scoping Review.

Authors:  Elizabeth Kaselitz; Gurpreet K Rana; Michele Heisler
Journal:  Curr Diab Rep       Date:  2017-08       Impact factor: 4.810

Review 2.  Do We Need Updated Guidelines on the Use of Insulin Pump Therapy in Type 2 Diabetes? A Review of National and International Practice Guidelines.

Authors:  Ohad Cohen; William Valentine
Journal:  J Diabetes Sci Technol       Date:  2016-11-01

Review 3.  Diabetes Prevention Interventions in Latin American Countries: a Scoping Review.

Authors:  Michele Heisler; Elizabeth Kaselitz; Gurpreet K Rana; John D Piette
Journal:  Curr Diab Rep       Date:  2016-09       Impact factor: 4.810

4.  Implementation and Outcomes of a Comprehensive Type 2 Diabetes Program in Rural Guatemala.

Authors:  David Flood; Sandy Mux; Boris Martinez; Pablo García; Kate Douglas; Vera Goldberg; Waleska Lopez; Peter Rohloff
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

5.  Antihyperglycemic Activity of the Leaves from Annona cherimola Miller and Rutin on Alloxan-induced Diabetic Rats.

Authors:  Fernando Calzada; Jesús Iván Solares-Pascasio; R M Ordoñez-Razo; Claudia Velazquez; Elizabeth Barbosa; Normand García-Hernández; David Mendez-Luna; José Correa-Basurto
Journal:  Pharmacognosy Res       Date:  2017 Jan-Mar

Review 6.  From Sea to Shining Sea and the Great Plains to Patagonia: A Review on Current Knowledge of Diabetes Mellitus in Hispanics/Latinos in the US and Latin America.

Authors:  M Larissa Avilés-Santa; Uriyoán Colón-Ramos; Nangel M Lindberg; Josiemer Mattei; Francisco J Pasquel; Cynthia M Pérez
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-10       Impact factor: 5.555

7.  Subjects with impaired fasting glucose: evolution in a period of 6 years.

Authors:  E Leiva; V Mujica; R Orrego; S Wehinger; A Soto; G Icaza; M Vásquez; L Díaz; M Andrews; M Arredondo
Journal:  J Diabetes Res       Date:  2014-08-20       Impact factor: 4.011

8.  Evaluation of the Capillary Blood Glucose Self-monitoring Program.

Authors:  Mariana Cristina Augusto; Maria José Trevizani Nitsche; Cristina Maria Garcia de Lima Parada; Maria Lúcia Zanetti; Maria Antonieta de Barros Leite Carvalhaes
Journal:  Rev Lat Am Enfermagem       Date:  2014-10

9.  Challenges associated with insulin therapy progression among patients with type 2 diabetes: Latin American MOSAIc study baseline data.

Authors:  Bruno Linetzky; Brad Curtis; Gustavo Frechtel; Renan Montenegro; Miguel Escalante Pulido; Oded Stempa; Janaina Martins de Lana; Juan José Gagliardino
Journal:  Diabetol Metab Syndr       Date:  2016-07-22       Impact factor: 3.320

10.  Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: Latin American subpopulation analysis of a randomized trial.

Authors:  Arturo Rojas; Georgina Sposetti; Jorge L Gross; Douglas Eugenio Barbieri; Ran Duan; Bruno Linetzky; Janaina Martins De Lana; Oded Stempa; Angel Rodriguez
Journal:  Diabetol Metab Syndr       Date:  2016-09-17       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.